{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:22:27Z","timestamp":1772810547520,"version":"3.50.1"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00417-025-07031-0","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T09:12:04Z","timestamp":1765530724000},"page":"617-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The spectrum of pachychoroid neovasculopathy"],"prefix":"10.1007","volume":"264","author":[{"given":"Stefano","family":"Lingardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Balduzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Menean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-9581","authenticated-orcid":false,"given":"Giuseppe","family":"Querques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"7031_CR1","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","volume":"33","author":"DJ Warrow","year":"2013","unstructured":"Warrow DJ, Hoang QV, Freund KB (2013) Pachychoroid pigment epitheliopathy. Retina 33:1659\u20131672. https:\/\/doi.org\/10.1097\/IAE.0b013e3182953df4","journal-title":"Retina"},{"key":"7031_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","volume":"33","author":"CMG Cheung","year":"2019","unstructured":"Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB (2019) Pachychoroid disease. Eye (Lond) 33:14\u201333. https:\/\/doi.org\/10.1038\/s41433-018-0158-4","journal-title":"Eye (Lond)"},{"key":"7031_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/IAE.0000000000003057","volume":"41","author":"RF Spaide","year":"2021","unstructured":"Spaide RF (2021) The ambiguity of pachychoroid. Retina 41:231\u2013237. https:\/\/doi.org\/10.1097\/IAE.0000000000003057","journal-title":"Retina"},{"key":"7031_CR4","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.oret.2019.08.002","volume":"3","author":"J Siedlecki","year":"2019","unstructured":"Siedlecki J, Schworm B, Priglinger SG (2019) The pachychoroid disease spectrum-and the need for a uniform classification system. Ophthalmol Retina 3:1013\u20131015. https:\/\/doi.org\/10.1016\/j.oret.2019.08.002","journal-title":"Ophthalmol Retina"},{"key":"7031_CR5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/00006982-200312000-00013","volume":"23","author":"RF Spaide","year":"2003","unstructured":"Spaide RF, Goldbaum M, Wong DW, Tang KC, Iida T (2003) Serous detachment of the retina. Retina 23:820\u2013846. https:\/\/doi.org\/10.1097\/00006982-200312000-00013","journal-title":"Retina"},{"key":"7031_CR6","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/IAE.0000000000001758","volume":"38","author":"Y Yanagi","year":"2018","unstructured":"Yanagi Y, Ting DSW, Ng WY, Lee SY, Mathur R, Chan CM, Yeo I, Wong TY, Cheung GCM (2018) Choroidal vascular hyperpermeability as a predictor of treatment response for polypoidal choroidal vasculopathy. Retina 38:1509\u20131517. https:\/\/doi.org\/10.1097\/IAE.0000000000001758","journal-title":"Retina"},{"key":"7031_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/IAE.0000000000000742","volume":"36","author":"KK Dansingani","year":"2016","unstructured":"Dansingani KK, Balaratnasingam C, Naysan J, Freund KB (2016) En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina 36:499\u2013516. https:\/\/doi.org\/10.1097\/IAE.0000000000000742","journal-title":"Retina"},{"key":"7031_CR8","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00417-018-4144-0","volume":"256","author":"M Karacorlu","year":"2018","unstructured":"Karacorlu M, Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I (2018) Long-term follow-up of pachychoroid pigment epitheliopathy and lesion characteristics. Graefes Arch Clin Exp Ophthalmol 256:2319\u20132326. https:\/\/doi.org\/10.1007\/s00417-018-4144-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7031_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/IAE.0000000000001655","volume":"38","author":"MG Ersoz","year":"2018","unstructured":"Ersoz MG, Karacorlu M, Arf S, Hocaoglu M, Sayman Muslubas I (2018) Outer nuclear layer thinning in pachychoroid pigment epitheliopathy. Retina 38:957\u2013961. https:\/\/doi.org\/10.1097\/IAE.0000000000001655","journal-title":"Retina"},{"key":"7031_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","volume":"35","author":"CE Pang","year":"2015","unstructured":"Pang CE, Freund KB (2015) Pachychoroid neovasculopathy. Retina 35:1\u20139. https:\/\/doi.org\/10.1097\/IAE.0000000000000331","journal-title":"Retina"},{"key":"7031_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ajo.2015.08.028","volume":"160","author":"KK Dansingani","year":"2015","unstructured":"Dansingani KK, Balaratnasingam C, Klufas MA, Sarraf D, Freund KB (2015) Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 160:1243\u20131254e2. https:\/\/doi.org\/10.1016\/j.ajo.2015.08.028","journal-title":"Am J Ophthalmol"},{"key":"7031_CR12","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1080\/02713683.2021.1942073","volume":"46","author":"R Hua","year":"2021","unstructured":"Hua R, Duan J, Zhang M (2021) Pachychoroid spectrum disease: underlying pathology, classification, and phenotypes. Curr Eye Res 46:1437\u20131448. https:\/\/doi.org\/10.1080\/02713683.2021.1942073","journal-title":"Curr Eye Res"},{"key":"7031_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/bjophthalmol-2017-310724","volume":"102","author":"MG Ersoz","year":"2018","unstructured":"Ersoz MG, Karacorlu M, Arf S, Hocaoglu M, Sayman Muslubas I (2018) Pachychoroid pigment epitheliopathy in fellow eyes of patients with unilateral central serous chorioretinopathy. Br J Ophthalmol 102:473\u2013478. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310724","journal-title":"Br J Ophthalmol"},{"key":"7031_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2022.100201","volume":"2","author":"M Yagi","year":"2022","unstructured":"Yagi M, Miyake M, Mori Y, Hosoda Y, Takahashi A, Muraoka Y, Ueda-Arakawa N, Miyata M, Yamashiro K, Tamura H, Ooto S, Tsujikawa A (2022) Natural course of pachychoroid pigment epitheliopathy. Ophthalmol Sci 2:100201. https:\/\/doi.org\/10.1016\/j.xops.2022.100201","journal-title":"Ophthalmol Sci"},{"key":"7031_CR15","first-page":"144","volume":"74","author":"A Dellaporta","year":"1976","unstructured":"Dellaporta A (1976) Central serous retinopathy. Trans Am Ophthalmol Soc 74:144\u2013153","journal-title":"Trans Am Ophthalmol Soc"},{"key":"7031_CR16","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1136\/bjo.2005.073056","volume":"89","author":"ME Van Velthoven","year":"2005","unstructured":"Van Velthoven ME, Verbraak FD, Garcia PM, Schlingemann RO, Rosen RB, de Smet MD (2005) Evaluation of central serous retinopathy with En face optical coherence tomography. Br J Ophthalmol 89:1483\u20131488. https:\/\/doi.org\/10.1136\/bjo.2005.073056","journal-title":"Br J Ophthalmol"},{"key":"7031_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100865","volume":"79","author":"R Kaye","year":"2020","unstructured":"Kaye R, Chandra S, Sheth J, Boon CJF, Sivaprasad S, Lotery A (2020) Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities. Prog Retin Eye Res 79:100865. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100865","journal-title":"Prog Retin Eye Res"},{"key":"7031_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82\u2013118. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.05.003","journal-title":"Prog Retin Eye Res"},{"key":"7031_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ajo.2009.11.017","volume":"149","author":"LA Yannuzzi","year":"2010","unstructured":"Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149:361\u2013363. https:\/\/doi.org\/10.1016\/j.ajo.2009.11.017","journal-title":"Am J Ophthalmol"},{"key":"7031_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/bjophthalmol-2018-312435","volume":"103","author":"SR Singh","year":"2019","unstructured":"Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, Peiretti E, Sivaprasad S, Lotery AJ, Boon CJF, Behar-Cohen F, Freund KB, Chhablani J (2019) Discrepancy in current central serous chorioretinopathy classification. Br J Ophthalmol 103:737\u2013742. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312435","journal-title":"Br J Ophthalmol"},{"key":"7031_CR21","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","volume":"32","author":"AT Fung","year":"2012","unstructured":"Fung AT, Yannuzzi LA, Freund KB (2012) Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina 32:1829\u20131837. https:\/\/doi.org\/10.1097\/IAE.0b013e3182680a66","journal-title":"Retina"},{"key":"7031_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/IAE.0000000000002810","volume":"41","author":"MC Savastano","year":"2021","unstructured":"Savastano MC, Rispoli M, Lumbroso B (2021) The incidence of neovascularization in central serous chorioretinopathy by optical coherence tomography angiography. Retina 41:302\u2013308. https:\/\/doi.org\/10.1097\/IAE.0000000000002810","journal-title":"Retina"},{"key":"7031_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","volume":"126","author":"S Mrejen","year":"2019","unstructured":"Mrejen S, Balaratnasingam C, Kaden TR, Bottini A, Dansingani K, Bhavsar KV, Yannuzzi NA, Patel S, Chen KC, Yu S, Stoffels G, Spaide RF, Freund KB, Yannuzzi LA (2019) Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology 126:576\u2013588. https:\/\/doi.org\/10.1016\/j.ophtha.2018.12.048","journal-title":"Ophthalmology"},{"key":"7031_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajo.2020.10.011","volume":"223","author":"E Borrelli","year":"2021","unstructured":"Borrelli E, Battista M, Sacconi R, Gelormini F, Querques L, Grosso D, Vella G, Bandello F, Querques G (2021) OCT risk factors for 3-year development of macular complications in eyes with resolved chronic central serous chorioretinopathy. Am J Ophthalmol 223:129\u2013139. https:\/\/doi.org\/10.1016\/j.ajo.2020.10.011","journal-title":"Am J Ophthalmol"},{"key":"7031_CR25","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ van Rijssen","year":"2019","unstructured":"van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, Sivaprasad S, Querques G, Downes SM, Fauser S, Hoyng CB, Piccolino FC, Chhablani JK, Lai TYY, Lotery AJ, Larsen M, Holz FG, Freund KB, Yannuzzi LA, Boon CJF (2019) Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res 73:100770. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.07.003","journal-title":"Prog Retin Eye Res"},{"key":"7031_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000104758","volume":"221","author":"M Moschos","year":"2007","unstructured":"Moschos M, Brouzas D, Koutsandrea C, Stefanos B, Loukianou H, Papantonis F, Moschos M (2007) Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography. Ophthalmologica 221:292\u2013298. https:\/\/doi.org\/10.1159\/000104758","journal-title":"Ophthalmologica"},{"key":"7031_CR27","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","volume":"29","author":"Y Imamura","year":"2009","unstructured":"Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29:1469\u20131473. https:\/\/doi.org\/10.1097\/IAE.0b013e3181be0a83","journal-title":"Retina"},{"key":"7031_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/IAE.0000000000002846","volume":"41","author":"E Borrelli","year":"2021","unstructured":"Borrelli E, Battista M, Gelormini F, Gabela MC, Pennisi F, Quarta A, Pezzella M, Sacconi R, Querques L, Bandello F, Querques G (2021) Photoreceptor outer segment is expanded in the fellow eye of patients with unilateral central serous chorioretinopathy. Retina 41:296\u2013301. https:\/\/doi.org\/10.1097\/IAE.0000000000002846","journal-title":"Retina"},{"key":"7031_CR29","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/IAE.0000000000003452","volume":"42","author":"E Borrelli","year":"2022","unstructured":"Borrelli E, Battista M, Barresi C, Grosso D, Gabela MC, Quarta A, Saladino A, Sacconi R, Querques L, Bandello F, Querques G (2022) Inner and outer choroidal changes in the fellow eye of patients with unilateral central serous chorioretinopathy. Retina 42:1238\u20131247. https:\/\/doi.org\/10.1097\/IAE.0000000000003452","journal-title":"Retina"},{"key":"7031_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ajo.2018.07.004","volume":"194","author":"C Rochepeau","year":"2018","unstructured":"Rochepeau C, Kodjikian L, Garcia MA, Coulon C, Burillon C, Denis P, Delaunay B, Mathis T (2018) Optical coherence tomography angiography quantitative assessment of choriocapillaris blood flow in central serous chorioretinopathy. Am J Ophthalmol 194:26\u201334. https:\/\/doi.org\/10.1016\/j.ajo.2018.07.004","journal-title":"Am J Ophthalmol"},{"key":"7031_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101236","volume":"101","author":"HMA Feenstra","year":"2024","unstructured":"Feenstra HMA, van Dijk EHC, Cheung CMG, Ohno-Matsui K, Lai TYY, Koizumi H, Larsen M, Querques G, Downes SM, Yzer S, Breazzano MP, Subhi Y, Tadayoni R, Priglinger SG, Pauleikhoff LJB, Lange CAK, Loewenstein A, Diederen RMH, Schlingemann RO, Hoyng CB, Chhablani JK, Holz FG, Sivaprasad S, Lotery AJ, Yannuzzi LA, Freund KB, Boon CJF (2024) Central serous chorioretinopathy: an evidence-based treatment guideline. Prog Retin Eye Res 101:101236. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101236","journal-title":"Prog Retin Eye Res"},{"key":"7031_CR32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","volume":"125","author":"EHC Van Dijk","year":"2018","unstructured":"Van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF (2018) Half-Dose photodynamic therapy versus High-Density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial. Ophthalmology 125:1547\u20131555. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.021","journal-title":"Ophthalmology"},{"key":"7031_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2020.04.007","volume":"216","author":"TJ Van Rijssen","year":"2020","unstructured":"Van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Dijkman G, Peters PJH, Tsonaka R, MacLaren RE, Downes SM, Fauser S, Boon CJF, Hoyng CB (2020) Crossover to photodynamic therapy or micropulse laser after failure of primary treatment of chronic central serous chorioretinopathy: the REPLACE trial. Am J Ophthalmol 216:80\u201389. https:\/\/doi.org\/10.1016\/j.ajo.2020.04.007","journal-title":"Am J Ophthalmol"},{"key":"7031_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.oret.2017.08.016","volume":"2","author":"A Takahashi","year":"2018","unstructured":"Takahashi A, Ooto S, Yamashiro K, Tamura H, Oishi A, Miyata M, Hata M, Yoshikawa M, Yoshimura N, Tsujikawa A (2018) Pachychoroid geographic atrophy: clinical and genetic characteristics. Ophthalmol Retina 2:295\u2013305. https:\/\/doi.org\/10.1016\/j.oret.2017.08.016","journal-title":"Ophthalmol Retina"},{"key":"7031_CR35","doi-asserted-by":"publisher","first-page":"100528","DOI":"10.1016\/j.xops.2024.100528","volume":"10","author":"Y Sato","year":"2024","unstructured":"Sato Y, Ueda-Arakawa N, Takahashi A, Miyake M, Mori Y, Miyara Y, Hara C, Kitajima Y, Maruko R, Kawai M, Takahashi H, Koizumi H, Maruyama-Inoue M, Yanagi Y, Iida T, Takahashi K, Sakamoto T, Tsujikawa A (2024) Clinical characteristics and progression of pachychoroid and conventional geographic atrophy. Ophthalmol Sci 10:4:100528. https:\/\/doi.org\/10.1016\/j.xops.2024.100528","journal-title":"Ophthalmol Sci"},{"issue":"25","key":"7031_CR36","doi-asserted-by":"publisher","first-page":"S2468","DOI":"10.1016\/j.oret.2025.04.005","volume":"11","author":"N Hasan","year":"2025","unstructured":"Hasan N, Zarnegar A, Jacob N, Sahoo N, Saju S, Zhou A, Wykoff CC, Winter H, Gill M, Silva R, Pereira P, Hertkorn F, Desideri LF, Munk MR, Villafuerte-Trisolini C, Yiu G, Wu L, Chhablani J, Macula Society International CSCR Research Network \u2013 MICRoN (2025) Clinical characteristics and progression of pachychoroid macular atrophy in central serous chorioretinopathy. Ophthalmol Retina 11(25):S2468\u20136530. https:\/\/doi.org\/10.1016\/j.oret.2025.04.005","journal-title":"Ophthalmol Retina"},{"key":"7031_CR37","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/IAE.0000000000000529","volume":"35","author":"E Peiretti","year":"2015","unstructured":"Peiretti E, Ferrara DC, Caminiti G, Mura M, Hughes J (2015) Choroidal neovascularization in Caucasian patients with longstanding central serous chorioretinopathy. Retina 35:1360\u20131367. https:\/\/doi.org\/10.1097\/IAE.0000000000000529","journal-title":"Retina"},{"key":"7031_CR38","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1177\/11206721211033474","volume":"32","author":"S Demirel","year":"2022","unstructured":"Demirel S, Yan\u0131k \u00d6, Bat\u0131o\u011flu F, \u00d6zmert E (2022) Treatment outcomes of photodynamic therapy and findings predicting treatment success in pachychoroid-associated neovascularization. Eur J Ophthalmol 32:1662\u20131670. https:\/\/doi.org\/10.1177\/11206721211033474","journal-title":"Eur J Ophthalmol"},{"key":"7031_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53357-1","volume":"9","author":"E Borrelli","year":"2019","unstructured":"Borrelli E, Sacconi R, Brambati M, Bandello F, Querques G (2019) In vivo rotational three-dimensional OCTA analysis of microaneurysms in the human diabetic retina. Sci Rep 9:16789. https:\/\/doi.org\/10.1038\/s41598-019-53357-1","journal-title":"Sci Rep"},{"key":"7031_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/bjophthalmol-2019-315800","volume":"105","author":"R Sacconi","year":"2021","unstructured":"Sacconi R, Corbelli E, Borrelli E, Capone L, Carnevali A, Gelormini F, Querques L, Bandello F, Querques G (2021) Choriocapillaris flow impairment could predict the enlargement of geographic atrophy lesion. Br J Ophthalmol 105:97\u2013102. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315800","journal-title":"Br J Ophthalmol"},{"key":"7031_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ajo.2020.04.025","volume":"218","author":"R Sacconi","year":"2020","unstructured":"Sacconi R, Borrelli E, Sadda S, Corradetti G, Freund KB, Yannuzzi LA, Souied E, Capuano V, Sarraf D, Querques L, Bandello F, Querques G (2020) Nonexudative perifoveal vascular anomalous complex: the subclinical stage of perifoveal exudative vascular anomalous complex? Am J Ophthalmol 218:59\u201367. https:\/\/doi.org\/10.1016\/j.ajo.2020.04.025","journal-title":"Am J Ophthalmol"},{"key":"7031_CR42","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1136\/bjophthalmol-2017-311240","volume":"102","author":"R Sacconi","year":"2018","unstructured":"Sacconi R, Corbelli E, Carnevali A, Mercuri S, Rabiolo A, Querques L, Marchini G, Bandello F, Querques G (2018) Optical coherence tomography angiography in pseudophakic cystoid macular oedema compared to diabetic macular oedema: qualitative and quantitative evaluation of retinal vasculature. Br J Ophthalmol 102:1684\u20131690. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311240","journal-title":"Br J Ophthalmol"},{"key":"7031_CR43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00417-021-05450-3","volume":"260","author":"TJMM Mazzeo","year":"2022","unstructured":"Mazzeo TJMM, Leber HM, da Silva AG, Freire RCM, Barbosa GCS, Criado GG, Jacob GAV, Machado CG, Gomes AMV (2022) Pachychoroid disease spectrum: review article. Graefes Arch Clin Exp Ophthalmol 260:723\u2013735. https:\/\/doi.org\/10.1007\/s00417-021-05450-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7031_CR44","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.4103\/ijo.IJO_377_18","volume":"66","author":"J Sheth","year":"2018","unstructured":"Sheth J, Anantharaman G, Chandra S, Sivaprasad S (2018) Double-layer sign on spectral domain optical coherence tomography in pachychoroid spectrum disease. Indian J Ophthalmol 66:1796\u20131801. https:\/\/doi.org\/10.4103\/ijo.IJO_377_18","journal-title":"Indian J Ophthalmol"},{"key":"7031_CR45","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1007\/s00417-024-06585-9","volume":"262","author":"V Capuano","year":"2024","unstructured":"Capuano V, Sacconi R, Miere A, Borrelli E, Amoroso F, Costanzo E, Parravano M, Fragiotta S, Bandello F, Souied EH, Querques G (2024) The triple-layer sign: an optical coherence tomography signature for the detection of non-exudative macular neovascularization. Graefes Arch Clin Exp Ophthalmol 262:3847\u20133855. https:\/\/doi.org\/10.1007\/s00417-024-06585-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7031_CR46","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/IAE.0000000000001580","volume":"38","author":"E Bousquet","year":"2018","unstructured":"Bousquet E, Bonnin S, Mrejen S, Krivosic V, Tadayoni R, Gaudric A (2018) Optical coherence tomography angiography of flat irregular pigment epithelium detachment in chronic central serous chorioretinopathy. Retina 38:629\u2013638. https:\/\/doi.org\/10.1097\/IAE.0000000000001580","journal-title":"Retina"},{"key":"7031_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.preteyeres.2018.07.002","volume":"67","author":"E Borrelli","year":"2018","unstructured":"Borrelli E, Sarraf D, Freund KB, Sadda SR (2018) Oct angiography and evaluation of the choroid and choroidal vascular disorders. Prog Retin Eye Res 67:30\u201355. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.07.002","journal-title":"Prog Retin Eye Res"},{"key":"7031_CR48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ajo.2021.05.029","volume":"232","author":"DS Ng","year":"2021","unstructured":"Ng DS, Ho M, Chen LJ, Yip FL, Teh WM, Zhou L, Mohamed S, Tsang CW, Brel\u00e9n ME, Chen H, Pang CP, Lai TYY (2021) Optical coherence tomography angiography compared with multimodal imaging for diagnosing neovascular central serous chorioretinopathy. Am J Ophthalmol 232:70\u201382. https:\/\/doi.org\/10.1016\/j.ajo.2021.05.029","journal-title":"Am J Ophthalmol"},{"key":"7031_CR49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3928\/23258160-20160126-05","volume":"47","author":"TE De Carlo","year":"2016","unstructured":"De Carlo TE, Rosenblatt A, Goldstein M, Baumal CR, Loewenstein A, Duker JS (2016) Vascularization of irregular retinal pigment epithelial detachments in chronic central serous chorioretinopathy evaluated with OCT angiography. Ophthalmic Surg Lasers Imaging Retina 47:128\u2013133. https:\/\/doi.org\/10.3928\/23258160-20160126-05","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"7031_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3048013","volume":"2017","author":"J Go\u0142\u0119biewska","year":"2017","unstructured":"Go\u0142\u0119biewska J, Brydak-Godowska J, Moneta-Wielgo\u015b J, Turczy\u0144ska M, K\u0119cik D, Hautz W (2017) Correlation between choroidal neovascularization shown by OCT angiography and choroidal thickness in patients with chronic central serous chorioretinopathy. J Ophthalmol 2017:3048013. https:\/\/doi.org\/10.1155\/2017\/3048013","journal-title":"J Ophthalmol"},{"key":"7031_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.103126","volume":"40","author":"Y Su","year":"2022","unstructured":"Su Y, Zhang X, Gan Y, Zeng Y, Wen F (2022) Detection of pachychoroid neovasculopathy with optical coherence tomography angiography versus dye angiography imaging. Photodiagnosis Photodyn Ther 40:103126. https:\/\/doi.org\/10.1016\/j.pdpdt.2022.103126","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"7031_CR52","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00417-022-05924-y","volume":"261","author":"E Borrelli","year":"2023","unstructured":"Borrelli E, Vigan\u00f2 C, Battista M, Sacconi R, Senni C, Querques L, Grosso D, Bandello F, Querques G (2023) Individual vs. combined imaging modalities for diagnosing neovascular central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 261:1267\u20131273. https:\/\/doi.org\/10.1007\/s00417-022-05924-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7031_CR53","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3928\/23258160-20201104-06","volume":"51","author":"\u00d6 Bi\u00e7er","year":"2020","unstructured":"Bi\u00e7er \u00d6, Demirel S, Yavuz Z, Batio\u011flu F, \u00d6zmert E (2020) Comparison of morphological features of type 1 CNV in AMD and pachychoroid neovasculopathy: an OCTA study. Ophthalmic Surg Lasers Imaging Retina 51:640\u2013647. https:\/\/doi.org\/10.3928\/23258160-20201104-06","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"7031_CR54","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1038\/s41598-021-83650-x","volume":"11","author":"GW Lee","year":"2021","unstructured":"Lee GW, Roh HC, Kang SW, Kim AY, Noh H, Choi KJ (2021) The implications of subretinal fluid in pachychoroid neovasculopathy. Sci Rep 11:4066. https:\/\/doi.org\/10.1038\/s41598-021-83650-x","journal-title":"Sci Rep"},{"key":"7031_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.oret.2017.01.003","volume":"1","author":"A Carnevali","year":"2017","unstructured":"Carnevali A, Capuano V, Sacconi R, Querques L, Marchese A, Rabiolo A, Souied E, Scorcia V, Bandello F, Querques G (2017) OCT angiography of treatment-na\u00efve quiescent choroidal neovascularization in pachychoroid neovasculopathy. Ophthalmol Retina 1:328\u2013332. https:\/\/doi.org\/10.1016\/j.oret.2017.01.003","journal-title":"Ophthalmol Retina"},{"key":"7031_CR56","doi-asserted-by":"publisher","first-page":"6886","DOI":"10.1167\/iovs.13-11665","volume":"54","author":"G Querques","year":"2013","unstructured":"Querques G, Srour M, Massamba N, Georges A, Ben Moussa N, Rafaeli O, Souied EH (2013) Functional characterization and multimodal imaging of treatment-naive quiescent choroidal neovascularization. Invest Ophthalmol Vis Sci 54:6886\u20136892. https:\/\/doi.org\/10.1167\/iovs.13-11665","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7031_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101113","volume":"92","author":"R Sacconi","year":"2023","unstructured":"Sacconi R, Fragiotta S, Sarraf D, Sadda SR, Freund KB, Parravano M, Corradetti G, Cabral D, Capuano V, Miere A, Costanzo E, Bandello F, Souied E, Querques G (2023) Towards a better understanding of non-exudative choroidal and macular neovascularization. Prog Retin Eye Res 92:101113. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101113","journal-title":"Prog Retin Eye Res"},{"key":"7031_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ajo.2016.06.042","volume":"169","author":"A Carnevali","year":"2016","unstructured":"Carnevali A, Cicinelli MV, Capuano V, Corvi F, Mazzaferro A, Querques L, Scorcia V, Souied EH, Bandello F, Querques G (2016) Optical coherence tomography angiography: a useful tool for diagnosis of treatment-na\u00efve quiescent choroidal neovascularization. Am J Ophthalmol 169:189\u2013198. https:\/\/doi.org\/10.1016\/j.ajo.2016.06.042","journal-title":"Am J Ophthalmol"},{"key":"7031_CR59","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/s41433-019-0511-2","volume":"33","author":"R Sacconi","year":"2019","unstructured":"Sacconi R, Tomasso L, Corbelli E, Carnevali A, Querques L, Casati S, Bandello F, Querques G (2019) Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study. Eye (Lond) 33:1809\u20131817. https:\/\/doi.org\/10.1038\/s41433-019-0511-2","journal-title":"Eye (Lond)"},{"key":"7031_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep16204","volume":"5","author":"M Miyake","year":"2015","unstructured":"Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, Ueda-Arakawa N, Oishi A, Nakanishi H, Tamura H, Tsujikawa A, Yoshimura N (2015) Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep 5:16204. https:\/\/doi.org\/10.1038\/srep16204","journal-title":"Sci Rep"},{"key":"7031_CR61","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1055\/s-0032-1315077","volume":"229","author":"W Inhoffen","year":"2012","unstructured":"Inhoffen W, Ziemssen F, Bartz-Schmidt KU (2012) Chronic central serous chorioretinopathy (cCSC): differential diagnosis to choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD). Klin Monbl Augenheilkd 229:889\u2013896. https:\/\/doi.org\/10.1055\/s-0032-1315077","journal-title":"Klin Monbl Augenheilkd"},{"key":"7031_CR62","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-14959","volume":"55","author":"CE Pang","year":"2014","unstructured":"Pang CE, Freund KB (2014) Pachychoroid pigment epitheliopathy may masquerade as acute retinal pigment epitheliitis. Invest Ophthalmol Vis Sci 55:5252. https:\/\/doi.org\/10.1167\/iovs.14-14959","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7031_CR63","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ajo.2015.06.016","volume":"160","author":"M Quaranta-El Maftouhi","year":"2015","unstructured":"Quaranta-El Maftouhi M, El Maftouhi A, Eandi CM (2015) Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am J Ophthalmol 160:581\u2013587e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.06.016","journal-title":"Am J Ophthalmol"},{"key":"7031_CR64","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/eye.2018.2","volume":"32","author":"T Soomro","year":"2018","unstructured":"Soomro T, Talks J, Medscape (2018) The use of optical coherence tomography angiography for detecting choroidal neovascularization, compared to standard multimodal imaging. Eye (Lond) 32:661\u2013672. https:\/\/doi.org\/10.1038\/eye.2018.2","journal-title":"Eye (Lond)"},{"key":"7031_CR65","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/eye.2017.295","volume":"32","author":"R Sacconi","year":"2018","unstructured":"Sacconi R, Baldin G, Carnevali A, Querques L, Rabiolo A, Marchini G, Bandello F, Querques G (2018) Response of central serous chorioretinopathy evaluated by multimodal retinal imaging. Eye (Lond) 32:734\u2013742. https:\/\/doi.org\/10.1038\/eye.2017.295","journal-title":"Eye (Lond)"},{"key":"7031_CR66","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10384-020-00740-5","volume":"64","author":"Y Yanagi","year":"2020","unstructured":"Yanagi Y (2020) Pachychoroid disease: a new perspective on exudative maculopathy. Jpn J Ophthalmol 64:323\u2013337. https:\/\/doi.org\/10.1007\/s10384-020-00740-5","journal-title":"Jpn J Ophthalmol"},{"key":"7031_CR67","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1167\/iovs.17-22360","volume":"58","author":"E Borrelli","year":"2017","unstructured":"Borrelli E, Uji A, Sarraf D, Sadda SR (2017) Alterations in the choriocapillaris in intermediate age-related macular degeneration. Invest Ophthalmol Vis Sci 58:4792\u20134798. https:\/\/doi.org\/10.1167\/iovs.17-22360","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7031_CR68","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/IAE.0000000000002635","volume":"40","author":"Y Sakurada","year":"2020","unstructured":"Sakurada Y, Fragiotta S, Leong BCS, Parikh R, Hussnain SA, Freund KB (2020) Relationship between choroidal vascular hyperpermeability, choriocapillaris flow density, and choroidal thickness in eyes with pachychoroid pigment epitheliopathy. Retina 40:657\u2013662. https:\/\/doi.org\/10.1097\/IAE.0000000000002635","journal-title":"Retina"},{"key":"7031_CR69","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"27","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB et al (2020) Consensus nomenclature for reporting neovascular Age-Related macular degeneration data: consensus on neovascular Age-Related macular degeneration nomenclature study group. Ophthalmology 27:616\u2013636. https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.004","journal-title":"Ophthalmology"},{"key":"7031_CR70","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.survophthal.2017.06.005","volume":"63","author":"MV Cicinelli","year":"2018","unstructured":"Cicinelli MV, Rabiolo A, Sacconi R, Carnevali A, Querques L, Bandello F, Querques G (2018) Optical coherence tomography angiography in dry age-related macular degeneration. Surv Ophthalmol 63:236\u2013244. https:\/\/doi.org\/10.1016\/j.survophthal.2017.06.005","journal-title":"Surv Ophthalmol"},{"key":"7031_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77566-1","volume":"10","author":"E Borrelli","year":"2020","unstructured":"Borrelli E, Battista M, Gelormini F, Sacconi R, Querques L, Vella G, Vigan\u00f2 C, Bandello F, Querques G (2020) Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease. Sci Rep 10:20344. https:\/\/doi.org\/10.1038\/s41598-020-77566-1","journal-title":"Sci Rep"},{"key":"7031_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75451-5","volume":"10","author":"Y Hosoda","year":"2020","unstructured":"Hosoda Y, Miyake M, Yamashiro K, Ooto S, Takahashi A, Oishi A, Miyata M, Uji A, Muraoka Y, Tsujikawa A (2020) Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration. Sci Rep 10:18423. https:\/\/doi.org\/10.1038\/s41598-020-75451-5","journal-title":"Sci Rep"},{"key":"7031_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06968-0","volume":"12","author":"GM Cozzupoli","year":"2022","unstructured":"Cozzupoli GM, Borrelli E, Capuano V, Sacconi R, Astroz P, Battista M, Bandello F, Souied E, Querques G (2022) InCASEOf scoring system for distinction between pachychoroid-associated macular neovascularization and neovascular age-related macular degeneration in patients older than 50 years. Sci Rep 12:2938. https:\/\/doi.org\/10.1038\/s41598-022-06968-0","journal-title":"Sci Rep"},{"key":"7031_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","volume":"10","author":"LA Yannuzzi","year":"1990","unstructured":"Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10:1\u20138","journal-title":"Retina"},{"key":"7031_CR75","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, Gomi F, Koh AH, Lee WK, Wong TY (2018) Polypoidal choroidal vasculopathy: Definition, Pathogenesis, Diagnosis, and management. Ophthalmology 125:708\u2013724. https:\/\/doi.org\/10.1016\/j.ophtha.2017.11.019","journal-title":"Ophthalmology"},{"key":"7031_CR76","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/ceo.13114","volume":"46","author":"KK Dansingani","year":"2018","unstructured":"Dansingani KK, Gal-Or O, Sadda SR, Yannuzzi LA, Freund KB (2018) Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of \u2018expanded spectra\u2019 - a review. Clin Exp Ophthalmol 46:189\u2013200. https:\/\/doi.org\/10.1111\/ceo.13114","journal-title":"Clin Exp Ophthalmol"},{"key":"7031_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0000000000000774","volume":"36","author":"C Balaratnasingam","year":"2016","unstructured":"Balaratnasingam C, Lee WK, Koizumi H, Dansingani K, Inoue M, Freund KB (2016) Polypoidal choroidal vasculopathy: a distinct disease or manifestation of many? Retina 36:1\u20138. https:\/\/doi.org\/10.1097\/IAE.0000000000000774","journal-title":"Retina"},{"key":"7031_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13101680","volume":"13","author":"J Zhao","year":"2023","unstructured":"Zhao J, Chandrasekaran PR, Cheong KX, Wong M, Teo K (2023) New concepts for the diagnosis of polypoidal choroidal vasculopathy. Diagnostics 13:1680. https:\/\/doi.org\/10.3390\/diagnostics13101680","journal-title":"Diagnostics"},{"key":"7031_CR79","first-page":"417","volume":"109","author":"Japanese Study Group of Polypoidal Choroidal Vasculopathy","year":"2005","unstructured":"Japanese Study Group of Polypoidal Choroidal Vasculopathy (2005) [Criteria for diagnosis of polypoidal choroidal vasculopathy]. Nippon Ganka Gakkai Zasshi 109:417\u2013427","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"7031_CR80","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","volume":"32","author":"A Koh","year":"2012","unstructured":"Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with Ranibizumab or alone versus Ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32:1453\u20131464. https:\/\/doi.org\/10.1097\/IAE.0b013e31824f91e8","journal-title":"Retina"},{"key":"7031_CR81","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","volume":"128","author":"CMG Cheung","year":"2021","unstructured":"Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen SJ, Kim JE, Gomi F, Koh AH, Kokame G, Jordan-Yu JM, Corvi F, Invernizzi A, Ogura Y, Tan C, Mitchell P, Gupta V, Chhablani J, Chakravarthy U, Sadda SR, Wong TY, Staurenghi G, Lee WK (2021) Polypoidal choroidal vasculopathy: consensus nomenclature and Non-Indocyanine green angiograph diagnostic criteria from the Asia-Pacific ocular imaging society PCV workgroup. Ophthalmology 128:443\u2013452. https:\/\/doi.org\/10.1016\/j.ophtha.2020.08.006","journal-title":"Ophthalmology"},{"key":"7031_CR82","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/IAE.0000000000000794","volume":"36","author":"R Liu","year":"2016","unstructured":"Liu R, Li J, Li Z, Yu S, Yang Y, Yan H, Zeng J, Tang S, Ding X (2016) Distinguishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography. Retina 36:778\u2013786. https:\/\/doi.org\/10.1097\/IAE.0000000000000794","journal-title":"Retina"},{"key":"7031_CR83","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ajo.2014.08.025","volume":"158","author":"G De Salvo","year":"2014","unstructured":"De Salvo G, Vaz-Pereira S, Keane PA, Tufail A, Liew G (2014) Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 158:1228\u20131238e1. https:\/\/doi.org\/10.1016\/j.ajo.2014.08.025","journal-title":"Am J Ophthalmol"},{"key":"7031_CR84","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamaophthalmol.2019.0565","volume":"137","author":"V Chaikitmongkol","year":"2019","unstructured":"Chaikitmongkol V, Kong J, Khunsongkiet P, Patikulsila D, Sachdeva M, Chavengsaksongkram P, Dejkriengkraikul C, Winaikosol P, Choovuthayakorn J, Watanachai N, Kunavisarut P, Ingviya T, Bressler NM (2019) Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy. JAMA Ophthalmol 137:661\u2013667. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0565","journal-title":"JAMA Ophthalmol"},{"key":"7031_CR85","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1097\/IAE.0000000000001391","volume":"37","author":"CMG Cheung","year":"2017","unstructured":"Cheung CMG, Yanagi Y, Mohla A, Lee SY, Mathur R, Chan CM, Yeo I, Wong TY (2017) Characterization and differentiation of polypoidal choroidal vasculopathy using swept source optical coherence tomography angiography. Retina 37:1464\u20131474. https:\/\/doi.org\/10.1097\/IAE.0000000000001391","journal-title":"Retina"},{"key":"7031_CR86","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1167\/iovs.15-18955","volume":"57","author":"M Wang","year":"2016","unstructured":"Wang M, Zhou Y, Gao SS, Liu W, Huang Y, Huang D, Jia Y (2016) Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 57:526\u2013532. https:\/\/doi.org\/10.1167\/iovs.15-18955","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7031_CR87","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00417-015-3228-3","volume":"254","author":"JY Kim","year":"2016","unstructured":"Kim JY, Kwon OW, Oh HS, Kim SH, You YS (2016) Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 254:1505\u20131510. https:\/\/doi.org\/10.1007\/s00417-015-3228-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7031_CR88","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ajo.2021.08.006","volume":"234","author":"F Corvi","year":"2022","unstructured":"Corvi F, Chandra S, Invernizzi A, Pace L, Viola F, Sivaprasad S, Staurenghi G, Cheung CMG, Teo KYC (2022) Multimodal imaging comparison of polypoidal choroidal vasculopathy between Asian and Caucasian populations. Am J Ophthalmol 234:108\u2013116. https:\/\/doi.org\/10.1016\/j.ajo.2021.08.006","journal-title":"Am J Ophthalmol"},{"key":"7031_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154614","volume":"11","author":"K Yamashiro","year":"2022","unstructured":"Yamashiro K, Yanagi Y, Koizumi H, Matsumoto H, Cheung CMG, Gomi F, Iida T, Tsujikawa A (2022) Relationship between pachychoroid and polypoidal choroidal vasculopathy. J Clin Med 11:4614. https:\/\/doi.org\/10.3390\/jcm11154614","journal-title":"J Clin Med"},{"key":"7031_CR90","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1167\/iovs.08-2134","volume":"49","author":"H Nakashizuka","year":"2008","unstructured":"Nakashizuka H, Mitsumata M, Okisaka S, Shimada H, Kawamura A, Mori R, Yuzawa M (2008) Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 49:4729\u20134737. https:\/\/doi.org\/10.1167\/iovs.08-2134","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7031_CR91","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1442-9071.2004.00827.x","volume":"32","author":"S Kuroiwa","year":"2004","unstructured":"Kuroiwa S, Tateiwa H, Hisatomi T, Ishibashi T, Yoshimura N (2004) Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Experiment Ophthalmol 32:297\u2013302. https:\/\/doi.org\/10.1111\/j.1442-9071.2004.00827.x","journal-title":"Clin Experiment Ophthalmol"},{"key":"7031_CR92","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1167\/iovs.18-25018","volume":"59","author":"M Lee","year":"2018","unstructured":"Lee M, Lee H, Kim HC, Chung H (2018) Changes in stromal and luminal areas of the choroid in pachychoroid diseases: insights into the pathophysiology of pachychoroid diseases. Invest Ophthalmol Vis Sci 59:4896\u20134908. https:\/\/doi.org\/10.1167\/iovs.18-25018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7031_CR93","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.oret.2022.04.004","volume":"6","author":"J Siedlecki","year":"2022","unstructured":"Siedlecki J, Klaas JE, Keidel LF, Asani B, Luft N, Priglinger SG, Schworm B (2022) Progression of pachychoroid neovasculopathy into aneurysmal type 1 choroidal neovascularization or polypoidal choroidal vasculopathy. Ophthalmol Retina 6:807\u2013813. https:\/\/doi.org\/10.1016\/j.oret.2022.04.004","journal-title":"Ophthalmol Retina"},{"key":"7031_CR94","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s10384-018-0562-0","volume":"62","author":"H Matsumoto","year":"2018","unstructured":"Matsumoto H, Hiroe T, Morimoto M, Mimura K, Ito A, Akiyama H (2018) Efficacy of treat-and-extend regimen with Aflibercept for pachychoroid neovasculopathy and type 1 neovascular age-related macular degeneration. Jpn J Ophthalmol 62:144\u2013150. https:\/\/doi.org\/10.1007\/s10384-018-0562-0","journal-title":"Jpn J Ophthalmol"},{"key":"7031_CR95","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/jop.2018.0107","volume":"35","author":"HJ Cho","year":"2019","unstructured":"Cho HJ, Jung SH, Cho S, Han JO, Park S, Kim JW (2019) Intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy. J Ocul Pharmacol Ther 35:174\u2013181. https:\/\/doi.org\/10.1089\/jop.2018.0107","journal-title":"J Ocul Pharmacol Ther"},{"key":"7031_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7063","volume":"6","author":"CY Cheng","year":"2015","unstructured":"Cheng CY, Yamashiro K, Chen LJ et al (2015) New loci and coding variants confer risk for age-related macular degeneration in East Asians. Nat Commun 6:6063. https:\/\/doi.org\/10.1038\/ncomms7063","journal-title":"Nat Commun"},{"key":"7031_CR97","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/bjophthalmol-2019-315189","volume":"104","author":"R Forte","year":"2020","unstructured":"Forte R, Coscas F, Serra R, Cabral D, Colantuono D, Souied EH (2020) Long-term follow-up of quiescent choroidal neovascularisation associated with age-related macular degeneration or pachychoroid disease. Br J Ophthalmol 104:1057\u20131063. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315189","journal-title":"Br J Ophthalmol"},{"key":"7031_CR98","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1167\/iovs.16-20967","volume":"58","author":"M Hata","year":"2017","unstructured":"Hata M, Yamashiro K, Ooto S, Oishi A, Tamura H, Miyata M, Ueda-Arakawa N, Takahashi A, Tsujikawa A, Yoshimura N (2017) Intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 58:292\u2013298. https:\/\/doi.org\/10.1167\/iovs.16-20967","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7031_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248760","volume":"16","author":"A Miki","year":"2021","unstructured":"Miki A, Kusuhara S, Otsuji T, Kawashima Y, Miki K, Imai H, Nakamura M, Tsujikawa A (2021) Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy. PLoS One 16:e0248760. https:\/\/doi.org\/10.1371\/journal.pone.0248760","journal-title":"PLoS One"},{"key":"7031_CR100","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajo.2015.04.012","volume":"160","author":"RF Spaide","year":"2015","unstructured":"Spaide RF (2015) Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization. Am J Ophthalmol 160:6\u201316. https:\/\/doi.org\/10.1016\/j.ajo.2015.04.012","journal-title":"Am J Ophthalmol"},{"key":"7031_CR101","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000189797","volume":"46","author":"W Schierling","year":"2009","unstructured":"Schierling W, Troidl K, Troidl C, Schmitz-Rixen T, Schaper W, Eitenm\u00fcller IK (2009) The role of angiogenic growth factors in arteriogenesis. J Vasc Res 46:365\u2013374. https:\/\/doi.org\/10.1159\/000189797","journal-title":"J Vasc Res"},{"key":"7031_CR102","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11010-010-0517-3","volume":"343","author":"S Wu","year":"2010","unstructured":"Wu S, Wu X, Zhu W, Cai WJ, Schaper J, Schaper W (2010) Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis. Mol Cell Biochem 343:223\u2013229. https:\/\/doi.org\/10.1007\/s11010-010-0517-3","journal-title":"Mol Cell Biochem"},{"key":"7031_CR103","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00592-017-1010-1","volume":"54","author":"L Querques","year":"2017","unstructured":"Querques L, Parravano M, Sacconi R, Rabiolo A, Bandello F, Querques G (2017) Ischemic index changes in diabetic retinopathy after intravitreal dexamethasone implant using ultra-widefield fluorescein angiography: a pilot study. Acta Diabetol 54:769\u2013773. https:\/\/doi.org\/10.1007\/s00592-017-1010-1","journal-title":"Acta Diabetol"},{"key":"7031_CR104","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00417-024-06387-z","volume":"262","author":"N Tanaka","year":"2024","unstructured":"Tanaka N, Azuma K, Aoki S, Kitamoto K, Ueda K, Fujino R, Inoue T, Obata R (2024) Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes. Graefes Arch Clin Exp Ophthalmol 262:1811\u20131818. https:\/\/doi.org\/10.1007\/s00417-024-06387-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7031_CR105","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ajo.2010.10.030","volume":"151","author":"I Maruko","year":"2011","unstructured":"Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T (2011) Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 151:594\u2013603e1. https:\/\/doi.org\/10.1016\/j.ajo.2010.10.030","journal-title":"Am J Ophthalmol"},{"key":"7031_CR106","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/OPTH.S39584","volume":"7","author":"M Ratanasukon","year":"2013","unstructured":"Ratanasukon M, Thongthong K, Bhurayanontachai P, Jirarattanasopa P (2013) Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy. Clin Ophthalmol 7:87\u201392. https:\/\/doi.org\/10.2147\/OPTH.S39584","journal-title":"Clin Ophthalmol"},{"key":"7031_CR107","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s00417-024-06373-5","volume":"262","author":"YT Huang","year":"2024","unstructured":"Huang YT, Tien PT, Chen PY, Yang CL, Chen SN (2024) Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 262:1755\u20131763. https:\/\/doi.org\/10.1007\/s00417-024-06373-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7031_CR108","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","volume":"135","author":"A Koh","year":"2017","unstructured":"Koh A, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Feller C, Margaron P, Lim TH, Lee WK (2017) Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 135:1206\u20131213. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.4030","journal-title":"JAMA Ophthalmol"},{"key":"7031_CR109","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","volume":"138","author":"TH Lim","year":"2020","unstructured":"Lim TH, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Lee WK, Cheung CMG, Ngah NF, Patalauskaite R, Margaron P, Koh A, EVEREST II Study Group (2020) Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial. JAMA Ophthalmol 138:935\u2013942. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.2443","journal-title":"JAMA Ophthalmol"},{"key":"7031_CR110","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40123-024-00888-0","volume":"13","author":"KYC Teo","year":"2024","unstructured":"Teo KYC, Park KH, Ngah NF, Chen SJ, Ruamviboonsuk P, Mori R, Kondo N, Lee WK, Rajagopalan R, Obata R, Wong IYH, Chee C, Terasaki H, Sekiryu T, Chen SC, Yanagi Y, Honda S, Lai TYY, Cheung CMG (2024) Six-year outcomes in subjects with polypoidal choroidal vasculopathy in the EVEREST II study. Ophthalmol Ther 13:935\u2013954. https:\/\/doi.org\/10.1007\/s40123-024-00888-0","journal-title":"Ophthalmol Ther"},{"key":"7031_CR111","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2019.02.027","volume":"204","author":"TY Wong","year":"2019","unstructured":"Wong TY, Ogura Y, Lee WK, Iida T, Chen SJ, Mitchell P, Gemmy Cheung CM, Zhang Z, Leal S, Ishibashi T, PLANET Investigators (2019) Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the aflibercept in polypoidal choroidal vasculopathy study. Am J Ophthalmol 204:80\u201389. https:\/\/doi.org\/10.1016\/j.ajo.2019.02.027","journal-title":"Am J Ophthalmol"},{"key":"7031_CR112","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/bjophthalmol-2021-319090","volume":"106","author":"Y Ogura","year":"2022","unstructured":"Ogura Y, Jaffe GJ, Cheung CMG, Kokame GT, Iida T, Takahashi K, Lee WK, Chang AA, Mon\u00e9s J, D\u2019Souza D, Weissgerber G, Gedif K, Koh A (2022) Efficacy and safety of Brolucizumab versus Aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK. Br J Ophthalmol 106:994\u2013999. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319090","journal-title":"Br J Ophthalmol"},{"key":"7031_CR113","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00417-022-05793-5","volume":"261","author":"T Ueda-Consolvo","year":"2023","unstructured":"Ueda-Consolvo T, Tanigichi A, Numata A, Oiwake T, Nakamura T, Ishida M, Yanagisawa S, Hayashi A (2023) Switching to brolucizumab from aflibercept in age-related macular degeneration with type 1 macular neovascularization and polypoidal choroidal vasculopathy: an 18-month follow-up study. Graefes Arch Clin Exp Ophthalmol 261:345\u2013352. https:\/\/doi.org\/10.1007\/s00417-022-05793-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7031_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12216-2","volume":"12","author":"A Ito","year":"2022","unstructured":"Ito A, Maruyama-Inoue M, Kitajima Y, Ikeda S, Inoue T, Kadonosono K (2022) One-year outcomes of intravitreal brolucizumab injections in patients with polypoidal choroidal vasculopathy. Sci Rep 12:7987. https:\/\/doi.org\/10.1038\/s41598-022-12216-2","journal-title":"Sci Rep"},{"key":"7031_CR115","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/14712598.2022.2094239","volume":"22","author":"A Sharma","year":"2022","unstructured":"Sharma A, Parachuri N, Kumar N, Kuppermann BD, Loewenstein A, Bandello F (2022) Brolucizumab in polypoidal choroidal vasculopathy. Expert Opin Biol Ther 22:809\u2013812. https:\/\/doi.org\/10.1080\/14712598.2022.2094239","journal-title":"Expert Opin Biol Ther"},{"key":"7031_CR116","doi-asserted-by":"publisher","unstructured":"Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY, TENAYA, Investigators LUCERNE (2022) Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Lancet 19;399:729\u2013740. https:\/\/doi.org\/10.1016\/S0140-6736(22)00010-1","DOI":"10.1016\/S0140-6736(22)00010-1"},{"key":"7031_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35759-4","volume":"13","author":"R Mukai","year":"2023","unstructured":"Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T (2023) Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan. Sci Rep 13:8747. https:\/\/doi.org\/10.1038\/s41598-023-35759-4","journal-title":"Sci Rep"},{"key":"7031_CR118","doi-asserted-by":"publisher","unstructured":"Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T (2015) Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study. Br J Ophthalmol 99:1284-8. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306432","DOI":"10.1136\/bjophthalmol-2014-306432"},{"key":"7031_CR119","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00417-017-3718-6","volume":"255","author":"M Morimoto","year":"2017","unstructured":"Morimoto M, Matsumoto H, Mimura K, Akiyama H (2017) Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 255:1891\u20131897. https:\/\/doi.org\/10.1007\/s00417-017-3718-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7031_CR120","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.ophtha.2015.05.024","volume":"122","author":"A Yamamoto","year":"2015","unstructured":"Yamamoto A, Okada AA, Kano M, Koizumi H, Saito M, Maruko I, Sekiryu T, Iida T (2015) One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy. Ophthalmology 122:1866\u20131872. https:\/\/doi.org\/10.1016\/j.ophtha.2015.05.024","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07031-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07031-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07031-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:13:16Z","timestamp":1772791996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07031-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7031"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07031-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Stefano Lingardo, Edoardo Balduzzi, Federico Beretta, Matteo Menean: certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. Riccardo Sacconi is a consultant for: AbbVie (North Chicago, Illinois, USA), Bayer SheringPharma (Berlin, Germany), Carl Zeiss Meditec (Dublin, USA), Hoffmann-La-Roche (Basel, Switzerland), Novartis (Basel, Switzerland). Giuseppe Querques is a consultant for: AbbVie (North Chicago, Illinois, USA), Alimera Sciences (Alpharetta, Georgia, USA), Amgen (Thousand Oaks, USA), Heidelberg (Germany), KBH (Chengdu, China), LEH Pharma (London, UK), Lumithera (Poulsbo, USA), Novartis (Basel, Switzerland), Bayer Shering-Pharma (Berlin, Germany), Sandoz (Berlin, Germany), Sifi (Catania, Italy), Soof-Fidia (Albano, Italy), Zeiss (Dublin, USA).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}